Sonnet Biotherapeutics Inc. (NASDAQ: SONN) stock soars during pre-market session. Here’s to know why?
Sonnet Biotherapeutics Inc. (NASDAQ: SONN) stock gained by 1.32% at the last close while the SONN stock price rises by 9.89% in the pre-market trading session. Sonnet BioTherapeutics is a biotechnology-driven cancer firm with a patented platform for creating single or bispecific biologic medicines. What is happening? SONN announces the issuance of U.S. Patent number […]
